Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, providing promising developments across different clinical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, far more reputable different for therapeutic use, speci